Ashutosh Goel, Founder & MD

Mayank Goel, Founder & CEO

As per a report by Grand View Research, the Indian Pharma­ceutical Tablet Manufacturing market was valued at $17.79 billion in 2023 and is estimated to grow at a CAGR of 10.5 percent from 2024 to 2030. The market is driven by the in­creasing investment in R&D, advance­ments in manufacturing technologies, and the rising prevalence of chronic diseases among the elderly groups. Today, clients are in constant search of products that can effectively address and resolve the health challenges en­countered by people. 

However, major­ity of players in this sector are still al­locating minimal resources to research and innovation, hindering the devel­opment of breakthrough solutions for the market. Admed Pharma is at the forefront of addressing these challeng­es by developing innovative solutions that can successfully cure the complex health issues faced by people, setting new benchmarks in the industry.

Established in 2021, Admed Pharma is fully committed to developing products that are not only safe and effective but also meet the highest standards of quality at the same time. The firm has achieved excellence through the implementation and maintenance of a robust quality management system, which governs every stage of the manufacturing process. Right from the initial procurement of raw materials to stringent quality control checks at each production stage, the firm makes sure that its products consistently comply with latest regulatory requirements and surpass the client expectations. “We’ve reinforced dedication to advancing healthcare and improving the condition of patients through prioritizing safety, efficacy and reliability”, says Mayank Goel, Founder & CEO, Admed Pharma.

Cutting Edge Infrastructure

Admed Pharma has established itself as a strong entity in the market for nearly four years, producing around seven crore tablets each month. It remains fully committed to upholding the optimum level of quality standards while constantly striving for progress and improvement. “Today, we proudly cater to over 30 respected clients worldwide, which clearly indicates our growing influence and reputation in the healthcare industry”, mentions Ashutosh Goel, Founder & Managing Director, Admed Pharma. The firm is also equipped with advanced laboratories and equipment that acts as a catalyst in discovery and development processes.

Admed Pharma has adopted cutting-edge cloud-based ERP software to seamlessly drive operational excellence and efficiency. The platform fully optimizes key business functions including production, strategic planning, demand forecasting, financial management and budgeting. Furthermore, the system governs quality control and assurance, accelerating inventory and supply chain processes along with enhancing human resource and engineering operations.

Follows Strong Collaborative Approach

Admed Pharma has carefully appointed seasoned professionals of exceptional potential to oversee each department to achieve unparalleled efficiency and effectiveness. These individuals are not only highly qualified and experienced but are also deeply driven by a genuine passion towards their profession and an unwavering commitment to excellence. Through their professionalism they ensure that every facet of the organization operates with precision, purpose and a dedication to the highest standards of performance. The company also boasts a dedicated research and development team, which is committed to create new and innovative molecules. With over 400 drug formulations already in place, its team continues to introduce two to three new molecules every month, further pushing the boundaries of advancement in healthcare.

Admed Pharma strongly believes that the best results come through collaborative partnerships. That’s why it actively engages with industry leaders, healthcare professionals and academic institutions, combining collective expertise and resources to make a real difference in healthcare. The fusion of diverse scientific disciplines enables the firm to create an environment where creativity thrives. Furthermore, its collaborative approach not only helps to spark innovative ideas from the team but also allows for tackling challenges from diverse angles, leading to more effective and well-rounded solutions. The firm keeps trying new ingredients to improve its tablets and capsules, cutting costs of the medicines and finding innovative ways to enhance drug absorption, all in the pursuit of providing better solutions for patients.

Future Endeavors

Looking towards the future, Admed Pharma is dedicating its efforts to focused research that aligns with the evolving healthcare needs of current and future generations. By being closely aligned to these requirements, the firm aims to ensure that its work not only remains relevant in the long run but also create an everlasting, positive change in improving the health and well-being of people. The firm is also striving to obtain EU GMP plant certification, which will open new doors for it to valuable regulatory markets, not just in Europe, but also in Africa, CIF and many other countries.